QQ客服 官方微博 反馈留言

	Clinical efficacy and safety of synthetic thymic peptides with chemotherapy for non-small cell lung cancer in China: A systematic review and meta-analysis of 27 randomized controlled trials following the PRISMA guidelines
	Zeng, Fen-Lian; Xiao, Zheng; Wang, Cheng-Qiong; Jiang, Yuan; Shan, Jing-Li; Hu, Shan-Shan; Huang, Xiao-Rong; Tang, Yu-Hong; Yao, Xing-Sheng; Zhang, Tao
刊名	INTERNATIONAL IMMUNOPHARMACOLOGY
	2019
卷号	75
关键词	Non-small cell lung cancer Synthetic thymic peptides Thymosin alpha 1 Thymopentin Randomized controlled trial Meta-analysis
ISSN号	1567-5769
DOI	10.1016/j.intimp.2019.105747
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4217419
专题	武汉大学
推荐引用方式 GB/T 7714	Zeng, Fen-Lian,Xiao, Zheng,Wang, Cheng-Qiong,et al. Clinical efficacy and safety of synthetic thymic peptides with chemotherapy for non-small cell lung cancer in China: A systematic review and meta-analysis of 27 randomized controlled trials following the PRISMA guidelines[J]. INTERNATIONAL IMMUNOPHARMACOLOGY,2019,75.
APA	Zeng, Fen-Lian.,Xiao, Zheng.,Wang, Cheng-Qiong.,Jiang, Yuan.,Shan, Jing-Li.,...&Xiao, Xue.(2019).Clinical efficacy and safety of synthetic thymic peptides with chemotherapy for non-small cell lung cancer in China: A systematic review and meta-analysis of 27 randomized controlled trials following the PRISMA guidelines.INTERNATIONAL IMMUNOPHARMACOLOGY,75.
MLA	Zeng, Fen-Lian,et al."Clinical efficacy and safety of synthetic thymic peptides with chemotherapy for non-small cell lung cancer in China: A systematic review and meta-analysis of 27 randomized controlled trials following the PRISMA guidelines".INTERNATIONAL IMMUNOPHARMACOLOGY 75(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。